Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Carvedilol and Atorvastatin for Prevention of Contrast-Induced Nephropathy After Cardiac Catheterization

NCT03867994 is registered in ClinicalTrials.gov with rabab ahmed mohamed as lead sponsor.

NCT NCT03867994
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03867994 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Carvedilol and Atorvastatin for Prevention of Contrast-Induced Nephropathy After Cardiac Catheterization
Lead sponsor
rabab ahmed mohamed
Phase
Phase 2
Overall status
Completed
Start date
February 1, 2016
Completion date
May 15, 2017
Enrollment
144 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

contrast-induced nephropathy